Skip to content

Clinical trials

Phase 2/3 Migraine Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Phase: Phase 2/3 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20081
20102
20122
20151
20162
20175
20181
20191
20201
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status3
Terminated2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer5
Otsuka Pharmaceutical Co., Ltd.2
Allergan1
Brise Pharmaceuticals Co., Ltd.1
Canadian Memorial Chiropractic College1
Merck Sharp & Dohme LLC1
NMT Medical1
Nordlandssykehuset HF1
Oregon Health and Science University1
Pharmalyte Solutions LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders20
Headache4
Hyperacusis2
Nausea2
Photophobia2
Epilepsy1
Foramen Ovale, Patent1
Heart Septal Defects, Atrial1
Pain1
Post-Traumatic Headache1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.